Tuesday, 5 September 2017

Global and Europe Breast Biopsy Devices Market is expected to gain US$2,399 Mn by 2022 - Details Inside Analysis and Outlook to 2022

ResearchMoz added Latest Research Report titled " Global and Europe Breast Biopsy Devices Market - Analysis and Outlook to 2022 " to it's Large Report database.

This report presents a comprehensive overview of the Breast Biopsy Devices market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Breast Biopsy Devices industry.

This report focuses Global and Europe market, including details as following:

Key Players
Mammotome (U.S.)
Hologic (U.S.)
C.R Bard (U.S.)
Stryker (U.S.)
Galini SRL (Italy)
Medtronic (U.S.)

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1313806

Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain

Browse more details @ http://www.researchmoz.us/global-and-europe-breast-biopsy-devices-market-analysis-and-outlook-to-2022-report.html

Table of Contents

Global and Europe Breast Biopsy Devices Market - Analysis and Outlook to 2022
1 Market Outline
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Breast Biopsy Devices Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Breast Biopsy Devices Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Global and Europe Dermatology Drug Market - Analysis and Outlook to 2022: Key Players are J&J, Bayer, AbbVie, Pfizer, Novartis etc.

ResearchMoz added Latest Research Report titled " Global and Europe Dermatology Drug Market - Analysis and Outlook to 2022 " to it's Large Report database.

This report presents a comprehensive overview of the Dermatology Drug market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Dermatology Drug industry.

This report focuses Global and Europe market, including details as following:

Key Players
AbbVie (U.S.)
Johnson & Johnson (U.S.)
Bayer (Germany)
Galderma (Switzerland)
Bristol-Myers Squibb (U.S.)
Novartis (China)
Pfizer (U.S.)

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1313807

Merz Pharma (Germany)
Valeant (Canada)
LEO Pharma (Denmark)
GlaxoSmithKline (UK)

Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others

Browse more details @ http://www.researchmoz.us/global-and-europe-dermatology-drug-market-analysis-and-outlook-to-2022-report.html

Table of Contents

Global and Europe Dermatology Drug Market - Analysis and Outlook to 2022
1 Market Outline
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Dermatology Drug Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Dermatology Drug Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Global Robotic Surgery Market: Industry Analysis & Outlook 2017-2021 : Focus on Application of da Vinci Systems Worldwide

ResearchMoz added Latest Research Report titled " Global Robotic Surgery Market: Industry Analysis & Outlook (2017-2021) " to it's Large Report database.

Medical robotics is an advanced discipline within the field of robotics which involves the development of robots that can perform various medical tasks. Many people think specifically of surgical robotics when they hear the words “medical robotics.” Medical robotics has the potential to relieve strain on many health care systems by automating tasks, freeing up health care workers.

Medical robotics has the potential to greatly reduce the size of operating room teams, thus eliminating the risk of contamination. Medical robots may someday be able to perform complex tasks like monitoring patients while they are under anesthesia, or keeping track of patients in critical care. Robotic surgery systems are categorized in three different classes: supervisory-controlled systems, telesurgical systems, and shared-control systems.

The key factors driving the growth of the robotic surgery market are growing ageing population, increasing healthcare expenditure, rising economic growth, rising incidence of chronic and infectious diseases, growth in minimally invasive surgery (MIS) and hernia may rival dVP penetration.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1144777

Some noteworthy trends of this industry include adoption of micro and nano robots in urology surgical procedures, focus on the development of low-cost robotic surgical systems, increase in R&D activities and expanding use of robot in general surgery. However, the expansion of the market is hindered by risks of robotic surgery and challenges of laparoscope control.

The report “Global Robotic Surgery Market” provides a comprehensive study of the global market for medical robotics, along with focus on application of da Vinci systems worldwide. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises few large players such as Intuitive Surgical, Accuray and Stryker Corporation. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

Table of Content

1. Medical Robotics – An Overview
1.1 An Introduction
1.2 Types of Medical Robotics
1.3 Application of Medical Robotics

Browse more details @ http://www.researchmoz.us/global-robotic-surgery-market-industry-analysis-outlook-20172021-report.html

1.4 Robotic Surgery
1.5 Workflow in Robotic Surgical Procedure
1.6 Major Applications

2. da Vinci Surgical System – An Overview
2.1 An Introduction
2.2 Components of da Vinci Surgical System
2.3 Types of da Vinci Models

3. Global Robotic Surgery Market Analysis
3.1 Global Robotic Market by Segment
3.2 Global Medical Robotics and Computer Assisted Surgery Market
3.3 Global Medical Robotics and Computer Assisted Surgery Market Forecast

4. da Vinci Surgical System
4.1 Global da Vinci Installed Base by Volume
4.2 Global da Vinci Installed Base Forecast by Volume
4.3 da Vinci Installed Base - The US vs. International
4.4 da Vinci Installed Base Forecast - The US vs. International
4.5 Global da Vinci Installed Base Share by Region
4.6 Global Number of da Vinci Procedures
4.7 Number of Procedures – US vs. International
4.8 Number of Procedures Forecast – US vs. International

5. The US da Vinci Procedures
5.1 The US Gynecology Procedures
5.2 The US Gynecology Procedures Forecast
5.3 The US General Surgery Procedures
5.4 The US General Surgery Procedures Forecast
5.5 The US Urology Procedures

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Global Bio CMO Market: Size, Trends & Forecasts 2016-2021: Company Coverage are Lonza, Boehringer Ingelheim, Samsung Electronics

ResearchMoz added Latest Research Report titled " Global Bio CMO Market: Size, Trends & Forecasts (2016-2021) " to it's Large Report database.

Scope of the Report

The report entitled Global Bio CMO Market: Size, Trends & Forecasts (2016-2021), provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global biologics market by value, by top selling products, etc.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global bio CMO market has been forecasted for the years 2016-2021, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Lonza, Boehringer Ingelheim, Samsung Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=948217

Company Coverage

Lonza
Boehringer Ingelheim
Samsung Electronics (Samsung Biologics)

Executive Summary

Pharmaceutical industry comprise of discovering, developing, producing and marketing of drugs for medical use. Worlds largest pharmaceutical firms are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be divided into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. Biologics are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

Browse more details @ http://www.researchmoz.us/global-bio-cmo-market-size-trends-and-forecasts-2016-2021-report.html

Table of Content

1. Executive Summary

2. Introduction

2.1 Pharmaceutical Industry Overview
2.1.1 Segments of Pharmaceutical Industry (Drugs)
2.2 Biotechnology/Biologics Overview
2.3 Biosimilar Overview
2.4 Biologics/ Biosimilar Manufacturing
2.5 Bio CMO Overview

3. Global Market Analysis

3.1 Global Biologics Market: An Analysis
3.1.1 Global Biologics Market by Value
3.1.2 Global Biologics Market by Top Selling Drugs
3.1.3 Global Biologics Market by Product in Development
3.1.4 Global Biologics Manufacturing market by Value

3.2 Global Bio CMO Market: An Analysis
3.2.1 Global Bio CMO Market by Penetration Rate
3.2.2 Global Bio CMO Market by Value
3.2.3 Global Bio CMO Market by Capacity
3.2.4 Global Bio CMO Market by Segments

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension

ResearchMoz added Latest Research Report titled " Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis " to it's Large Report database.

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis

Summary

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque building up within blood vessels. As atheroma develops it causes the affected blood vessels to narrow, restricting blood flow to the body, brain or heart, depending on its location. It is also possible for the fibrous cap of this plaque to break off, triggering the coagulation cascade and causing a thrombus to form locally, which can completely occlude blood flow.

The treatments of CVD typically focus on prevention by controlling the risk factors of CVD. As such, the treatments usually fall within three categories: anti-hypertensives, which aim to alterblood pressure to within a normal range; anti-dyslipidemic drugs, which aim to modify lipid levels to a normal range; and anti-thrombotic drugs, which aim to either prevent a thrombus from formingby inhibiting the coagulation cascade or platelet aggregation.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1313843

There has been vast scientific innovation within the CVD therapeutics market over recent decades, particularly within the anti-dyslipidemia market, first with the introduction of statins such as Lipitor (atorvastatin), and more recently with the introduction of PCSK9 inhibitors. Innovation continues within the dyslipidemia pipeline, with a range of first-in-class molecular targets in the pipeline, including those that offer the promise of revolutionizing treatment by reversing the process of atherosclerosis.

Heart failure and pulmonary hypertension remain poorly treated, and are associated with poor prognosis. Heart failure in particular is associated with a five-year mortality rate of 50%. The large pipeline for heart failure includes a high proportion of first-in-class products relative to other CVD indications, and possesses the potential for breakthroughs in the treatment of this condition.

Scope

- With over 1,400 products in active development, the pipeline for CVD is extensive. Does current pipeline innovation hold the potential to change the CVD market in the near future?
- There are 320 first-in-class products in the CVD market that act on a novel molecular target thatis not present in an approved product across any indication in the pharmaceutical industry.

Browse more details @ http://www.researchmoz.us/frontier-pharma-cardiovascular-disease-diverse-first-in-class-molecular-targets-to-bridge-unmet-needs-in-pulmonary-hypertension-heart-failure-and-atherosclerosis-report.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Executive Summary 6
2.1 Robust pipeline with attempts to meet unmet need 6
2.2 Drugs targeting apolipoproteins and elements of the reverse lipid transport pathway offer potential new therapies for the treatment of dyslipidemia and atherosclerosis 6
2.3 Cardiovascular disease pipeline emphasizes move away from conventional areas towards targets related to transmembrane and extracellular signaling 6
3 The Case for Innovation 7
3.1 Growing Opportunities for Biologic Products 8
3.2 Diversification of Molecular Targets 8
3.3 Innovative First-in-Class Product Developments Remain Attractive 9
3.4 Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation 9
3.5 Sustained Innovation in Cardiovascular Disease 10
3.6 GBI Research Report Guidance 10
4 Clinical and Commercial Landscape 11
4.1 Cardiovascular Disease Overview 11
4.2 Symptoms, Disease Staging and Prognosis 12
4.2.1 Symptoms 12
4.2.2 Prognosis 12
4.3 Diagnosis 13
4.3.1 Blood Pressure Test 13
4.3.2 Tests for Dyslipidemia 14
4.3.3 Imaging Tests 14
4.3.4 Stress Testing 15
4.4 Epidemiology 15

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Global Mobile Health (mHealth) Technologies Market Prospects - Featuring Expert Panel Views from Industry Survey 2017

ResearchMoz added Latest Research Report titled " Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 " to it's Large Report database.

GBI Research’s latest report Mobile Health (mHealth) Technologies: Global Market Prospects – Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthcare IT industries – including organizations that already implement mHealth solutions and services, and those that do not. The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry. The findings from the survey and results from secondary research efforts have been amalgamated with GBI’s own analytical views to provide an assessment that is comprehensive in outlook.

mHealth is a branch of eHealth, and commonly defined as the use of modern information and communication technologies to meet needs of citizens, patients, healthcare professionals, healthcare providers as well as policy markets. It can have a significant impact on consumers and on all aspects of the pharmaceutical and healthcare sector, and companies are making large investments to leverage these technologies more effectively.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1144778

mHealth technologies are already a reality in both developed and developing countries, and their uptake is expected to significantly increase in the near future, particularly as the overall healthcare industry continues to shift towards value-based medicine, and due to the increasing need for more cost-effective means to deliver healthcare and to demonstrate the value and effectiveness of medical treatments.

The report features an overview of mHealth solutions and services and its place within the pharmaceutical industry. It examines the factors driving and necessitating the use of these technologies within this industry, and provides detailed examples of how different solutions could be used to provide direct benefits to pharmaceutical companies, healthcare institutions and patients. There is also an analysis of the main challenges surrounding these technologies, as well as case studies of how companies are already implementing mHealth, and deal with some of the challenges. Finally, based on the totality of the survey results and research, strategic recommendations are provided for the effective implementation of new mHealth initiatives.

Browse more details @ http://www.researchmoz.us/mobile-health-mhealth-technologies-global-market-prospects-featuring-expert-panel-views-from-industry-survey-2017-report.html

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 mHealth Technologies Overview 8
2.1 What are mHealth Technologies? 8
2.2 What Types of Services Can mHealth Technologies Provide? 9
2.3 What are the Main Objectives of mHealth Technologies? 9
2.4 Key Stakeholders Involved in the Funding and Provision of mHealth 10
2.5 Key Market Segments in the mHealth Market Space 12
2.5.1 Key Sub-segments of the Global mHealth Market 14
2.6 How Prevalent is the Use of mHealth Technologies by Healthcare Organizations? Results from Our Industry-Wide Survey 15

3 The Global mHealth Market: The Most Important Drivers and Restraints in 2017 18
3.1 What Are the Most Important Growth Drivers in the Global mHealth Market? – Results from our Industry-Wide Survey 18
3.1.1 Providing Cost-Effective Care to Patients through mHealth Solutions 19
3.1.2 Can the Value and Effectiveness of Treatments be Demonstrated through mHealth Solutions? 19
3.1.3 How Interested Are HCPs and Reimbursement Entities in mHealth? 20
3.1.4 Accelerated Penetration of Mobile Technology at a Global Level 20
3.1.5 mHealth Solutions Helping Pharma Companies Solve Gaps in R&D Productivity 20
3.1.6 Is Government Funding and Support for mHealth in Key Markets Making a Difference? 21
3.1.7 Other Important Growth Drivers in the mHealth Market in 2017 21
3.1.8 What Are the Most Important Growth Drivers in the mHealth Market by Region? Results from our Industry-Wide Survey 22

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Monday, 4 September 2017

Global and Europe Medical Adhesive Tapes Market - Analysis and Outlook to 2022: Key Players- 3M, J&J, Medtronic, Nichiban, Smith & Nephew etc.

ResearchMoz added Latest Research Report titled " Global and Europe Medical Adhesive Tapes Market - Analysis and Outlook to 2022 " to it's Large Report database.

This report presents a comprehensive overview of the Medical Adhesive Tapes market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Medical Adhesive Tapes industry.

This report focuses Global and Europe market, including details as following:

Key Players
3M Company (US)
Medtronic Plc (US)
Nitto Denko Corporation (Japan)
Johnson & Johnson (US)
Smith & Nephew Plc (UK)
Nichiban Co., Ltd. (Japan)

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1313808

A.M.G. Medical Inc. (CA)
Sterimed Medical Devices Pvt. Ltd. (IN)
Pinnacle Technologies (US)
Wuxi Beyon Medical Products Co., Ltd. (CN)

Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others

Browse more details @ http://www.researchmoz.us/global-and-europe-medical-adhesive-tapes-market-analysis-and-outlook-to-2022-report.html

 Table of Contents

Global and Europe Medical Adhesive Tapes Market - Analysis and Outlook to 2022
1 Market Outline
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2 Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Medical Adhesive Tapes Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Medical Adhesive Tapes Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/